deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06374797

A Study of Auxora in Patients With AKI and Injurious Lung Crosstalk (KOURAGE)

Auxora for the Treatment of AKI and Modulation of Injurious Crosstalk With the Lung: A Randomized Control Trial (KOURAGE)

Sponsor: CalciMedica, Inc.

Interventions Auxora Placebo
Updated 12 times since 2024 Last updated: Jan 29, 2026 Started: Jul 1, 2024 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Kidney Injury, this trial is ongoing. The trial is conducted by CalciMedica, Inc. and has accumulated 12 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Jan 2025 · 2 months · monthly snapshot~Jan 2025 – ~May 2025 · 4 months · monthly snapshotRecruiting~May 2025 – ~Jul 2025 · 2 months · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshotRecruiting~Feb 2026 – present · 6 months · monthly snapshotActive Not Recruiting

Change History

12 versions recorded
  1. Feb 2026 — Present [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  2. Oct 2025 — Feb 2026 [monthly]

    Recruiting PHASE2

  3. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2025 — Sep 2025 [monthly]

    Recruiting PHASE2

  5. May 2025 — Jul 2025 [monthly]

    Recruiting PHASE2

Show 7 earlier versions
  1. Jan 2025 — May 2025 [monthly]

    Recruiting PHASE2

  2. Nov 2024 — Jan 2025 [monthly]

    Recruiting PHASE2

  3. Oct 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  5. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  6. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  7. May 2024 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CalciMedica, Inc.
Data source: CalciMedica, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .